Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page previously displayed a 403 Forbidden error, and now presents the full study record for NCT04695470, including sections on study overview, eligibility criteria, design details, interventions (Fruquintinib with Sintilimab), primary outcomes, enrollment, and locations.
    Difference
    43%
    Check dated 2026-09-27T20:31:43.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, replacing the study details with a standard error page and site header/footer.
    Difference
    17%
    Check dated 2026-09-20T22:29:59.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Post-update, the page shows Revision: v3.6.6, replacing v3.6.5. This indicates a small behind-the-scenes update to the page software without changing displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T21:59:13.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The site now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor platform version update.
    Difference
    0.1%
    Check dated 2026-08-09T12:29:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small metadata/version change.
    Difference
    0.1%
    Check dated 2026-07-26T00:08:49.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.2 to v3.6.3, representing a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-04T13:20:16.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.